What is the 13F Pro Quality Score for YCBD?

13F Pro ranks cbdMD, Inc. (YCBD) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View YCBD's current score at https://13fpro.ai/company/YCBD (free sign-up required for the full ranking).

Which hedge funds own the most YCBD stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of YCBD include Worth Venture Partners,, CSS /IL, VANGUARD CAPITAL MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/YCBD as soon as new 13F filings post.

Where does 13F Pro source YCBD data?

All cbdMD, Inc. fundamentals and ownership data come directly from SEC EDGAR. cbdMD, Inc. files with the SEC under CIK 1644903. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is YCBD in?

cbdMD, Inc. (YCBD) is classified in the Consumer Staples sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/consumer-staples.

How often is YCBD research updated on 13F Pro?

YCBD's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

cbdMD, Inc.(YCBD)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Consumer Staples →NYSEsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1644903 YCBD stock profile & AI dashboard →

13F Pro Quality Score

22.8/100

Rank #2,741 of 2,962 stocks

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why YCBD Scores 23/100

exact factor attribution · 2026-09-11

YCBD's composite is driven by shareholder dilution, held back by scale and revenue growth. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Shareholder dilution

+2.2 pts

95th pct

Earnings growth

-1.0 pts

31th pct

Institutional flow

-1.5 pts

20th pct

Capital efficiency

-3.4 pts

16th pct

Profitability

-4.1 pts

23th pct

Free cash flow

-4.2 pts

22th pct

Earnings quality

-4.5 pts

5th pct

Revenue growth

-4.8 pts

26th pct

Scale

-5.9 pts

11th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

YCBD Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for cbdMD, Inc. (YCBD), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores YCBD at 22.8/100 on a 32-signal composite quality model, placing it at rank #2,741 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), cbdMD, Inc. reports quarterly revenue of $5.6M, net income of $-1.1M, free cash flow of $-460.2K. Top institutional holders of YCBD by reported 13-F value include Worth Venture Partners, CSS, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. YCBD trades on the NYSE exchange and files with the SEC under CIK 1644903. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate YCBD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for cbdMD, Inc. directly from SEC EDGAR. cbdMD, Inc.'s 13F Pro composite quality score has ranged between 10 and 32 since 2021, currently 22.8 — a declining long-term trajectory across 21 quarterly and live scoring snapshots.

✦

Fun facts about cbdMD, Inc.

Quirks, history, and lore behind YCBD — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. consumer wellness company · small-cap · listed on NYSE American · headquartered in North Carolina.
2
The Numbers
Annual revenue in the low tens of millions of dollars — this is a scrappy small-cap in a crowded, fast-growing market where most players are still fighting for shelf space.
3
The History
Founded around 2015 and went public shortly after the 2018 Farm Bill made its core ingredient federally legal — talk about good timing on the IPO.
4
The Secret
Its product line spans tinctures, topicals, gummies, and bath bombs — all built around a single non-intoxicating hemp-derived compound that wellness shoppers can't stop talking about.
5
The Lore
The company has partnered with professional athletes and sports organizations to normalize its products, leaning hard into the recovery and performance wellness angle.
6
The Giveaway
The ticker literally starts with the letters CBD — and no, that's not a coincidence. This Charlotte-based company put cannabidiol right in its name and on every label.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$5.6M

Net Income

Q2 2026

$-1.1M

Free Cash Flow

Q2 2026

$-460.2K

ROIC

Q2 2026

-55.1%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-1.5% YoY

$19.2MFY 2025

FY22 $35.4MFY23 $24.2MFY24 $19.5MFY25 $19.2M

Net Income

+44.8% YoY

$-2.0MFY 2025

FY22 $-70.1MFY23 $-22.9MFY24 $-3.7MFY25 $-2.0M

Operating Income

+34.8% YoY

$-2.2MFY 2025

FY22 $-78.3MFY23 $-22.5MFY24 $-3.3MFY25 $-2.2M

EPS (Diluted)

+92.4% YoY

$-1.09FY 2025

FY22 $-55.80FY23 $-13.32FY24 $-14.29FY25 $-1.09

Total Assets

-1.5% YoY

$10.4MFY 2025

FY22 $40.8MFY23 $16.2MFY24 $10.6MFY25 $10.4M

Total Debt

—FY 2025

FY22 $125.5KFY23 $9.00FY24 —FY25 —

Op. Cash Flow

-311.7% YoY

$-1.5MFY 2025

FY22 $-15.0MFY23 $-4.3MFY24 $-352.8KFY25 $-1.5M

Free Cash Flow

-201.5% YoY

$-1.6MFY 2025

FY22 $-15.7MFY23 $-4.6MFY24 $-542.8KFY25 $-1.6M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$19.2M -1.5%	$19.5M -19.3%	$24.2M -31.8%	$35.4M -20.4%	$44.5M +6.2%	$41.9M
Net Income	$-2.0M +44.8%	$-3.7M +83.9%	$-22.9M +67.3%	$-70.1M -199.6%	$-23.4M -285.6%	$12.6M
Operating Income	$-2.2M +34.8%	$-3.3M +85.3%	$-22.5M +71.3%	$-78.3M -299.0%	$-19.6M -11.6%	$-17.6M
EPS (Diluted)	$-1.09 +92.4%	$-14.29 -7.3%	$-13.32 +76.1%	$-55.80 -11772.3%	$-0.47 -267.9%	$0.28
Total Assets	$10.4M -1.5%	$10.6M -34.7%	$16.2M -60.3%	$40.8M -67.3%	$124.9M +12.7%	$110.8M
Total Debt	—	—	$9.00 -100.0%	$125.5K +15.1%	$109.0K -58.8%	$264.4K
Operating Cash Flow	$-1.5M -311.7%	$-352.8K +91.8%	$-4.3M +71.3%	$-15.0M -6.2%	$-14.1M -32.2%	$-10.7M
Free Cash Flow	$-1.6M -201.5%	$-542.8K +88.2%	$-4.6M +70.6%	$-15.7M -8.5%	$-14.4M -20.5%	$-12.0M

Get alerted when YCBD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for cbdMD, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of YCBD

Worth Venture Partners, LLC
$124.4K184,796 sh
CSS LLC/IL
$92.6K137,621 sh
VANGUARD CAPITAL MANAGEMENT LLC
$80.5K119,645 sh
CHAPIN DAVIS, INC.
$54.7K81,250 sh
ALESCO ADVISORS LLC
$46.1K68,513 sh
Chicago Partners Investment Group LLC
$45.0K78,098 sh
XTX Topco Ltd
$42.2K62,743 sh
JANE STREET GROUP, LLC
$36.6K54,401 sh
VANGUARD FIDUCIARY TRUST CO
$31.7K47,157 sh
UBS Group AG
$14.5K21,576 sh

Fund	Value	Shares
Worth Venture Partners, LLC	$124.4K	184,796
CSS LLC/IL	$92.6K	137,621
VANGUARD CAPITAL MANAGEMENT LLC	$80.5K	119,645
CHAPIN DAVIS, INC.	$54.7K	81,250
ALESCO ADVISORS LLC	$46.1K	68,513
Chicago Partners Investment Group LLC	$45.0K	78,098
XTX Topco Ltd	$42.2K	62,743
JANE STREET GROUP, LLC	$36.6K	54,401
VANGUARD FIDUCIARY TRUST CO	$31.7K	47,157
UBS Group AG	$14.5K	21,576

More Consumer Staples Companies

View all Consumer Staples →

ABEV

AMBEV S.A.

ABVE

Above Food Ingredients Inc.

ACI

Albertsons Companies, Inc.

ADM

Archer-Daniels-Midland Co

AFRI

Forafric Global PLC

AGCC

Agencia Comercial Spirits Ltd.

AGRO

Adecoagro S.A.

AGRZ

Agroz Inc.

Put YCBD on your watchlist

Track score changes the day cbdMD, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is YCBD a good stock to buy?

13F Pro's AI-powered analysis of cbdMD, Inc. (YCBD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for YCBD are available on the YCBD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. YCBD is classified as a small company.

Which hedge funds own YCBD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling YCBD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of cbdMD, Inc.'s investment landscape.